Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk

The use of atorvastatin is rapidly increasing among statins since the introduction of generics. However, only limited data are available on its current use and the effectiveness outside of randomised trials. The aim of the study was to assess low-density lipoprotein (LDL-C) levels in ambulatory pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Laufs, Ulrich, Karmann, Barbara, Pittrow, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989032/
https://www.ncbi.nlm.nih.gov/pubmed/27120330
http://dx.doi.org/10.1007/s00392-016-0991-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989032/
https://www.ncbi.nlm.nih.gov/pubmed/27120330
http://dx.doi.org/10.1007/s00392-016-0991-z

Ejemplares similares